CONTINUOUS ADMINISTRATION OF L-DOPA, INHIBITORS OF DOPA-DECARBOXYLASE, INHIBITORS OF CATECHOL-O-METHYLTRANSFERASE AND COMPOSITIONS, INTENDED FOR IT Russian patent published in 2017 - IPC A61K9/08 A61K31/195 A61K31/198 A61P25/16 

FIELD: pharmaceutics.

SUBSTANCE: group of inventions refers to pharmaceutics and medicine and relates to pharmaceutically acceptable composition containing levodopa, carbidopa and arginine in molar ratio of carbidopa and levodopa to arginine ranging from 1:2 to 1:3.5, or containing levodopa, carbidopa, meglumine with molar ratio of levodopa and carbidopa to meglumine ranging from 1:0.3 to 1:1.5, and also a method of treating neurological disorder or motor disorder in patient, requiring it, involving administering of pharmaceutically acceptable composition to above patient.

EFFECT: group of inventions provides preparing stable liquid composition, suitable for continuous administration, and effective treatment of motor disorder and/or neurological disorder.

17 cl, 9 ex, 18 tbl, 6 dwg